Gene Expression Profiling of FFPE Samples: A Titration Test

The gene expression analysis of formalin-fixed paraffin-embedded (FFPE) tissues is often hampered by poor RNA quality, which results from the oxidation, cross-linking and other chemical modifications induced by the inclusion in paraffin. Yet, FFPE samples are a valuable source for molecular studies...

Full description

Saved in:
Bibliographic Details
Published inTechnology in cancer research & treatment Vol. 21; p. 15330338221129710
Main Authors Manjunath, Harshitha Shobha, Al Khulaifi, Moza, Sidahmed, Heba, Ammar, Adham, Vadakekolathu, Jayakumar, Rutella, Sergio, Al-Mohannadi, Muneera Jassim, Elawad, Mamoun, Mifsud, William, Charles, Adrian, Maccalli, Cristina, Tomei, Sara
Format Journal Article
LanguageEnglish
Published Los Angeles, CA SAGE Publications 01.01.2022
Sage Publications Ltd
SAGE Publishing
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The gene expression analysis of formalin-fixed paraffin-embedded (FFPE) tissues is often hampered by poor RNA quality, which results from the oxidation, cross-linking and other chemical modifications induced by the inclusion in paraffin. Yet, FFPE samples are a valuable source for molecular studies and can provide great insights into disease progression and prognosis. With the advancement of genomic technologies, new methods have been established that offer reliable and accurate gene expression workflows on samples of poor quality. NanoString is a probe-based technology that allows the direct counting of the mRNA transcripts and can be applied to degraded samples. Here, we have tested 2 RNA extraction methods for FFPE samples, and we have performed a titration experiment to evaluate the impact of RNA degradation and RNA input on the gene expression profiles assessed using the NanoString IO360 panel. We have selected FFPE samples of different DV200 values and assessed them on the nCounter platform with 2 different amounts of input RNA. This study concludes that the nCounter is a robust and reliable platform to assess the gene expression of RNA samples with DV200 > 30%; its robustness and ease of use could be of particular benefit to clinical settings.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1533-0346
1533-0338
DOI:10.1177/15330338221129710